Current Pulse

Voice-Guided Auto-Injector
Auvi-Q (epinephrine injection, USP), from Sanofi, Bridgewater, NJ, is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Auvi-Q provides users with audible and visual cues, including a five-second injection countdown and an alert light to signal when the injection is complete. Auvi-Q also features an automatic retractable needle mechanism to help prevent accidental needle sticks.

“Patient feedback was a critical component to the development process for Auvi-Q,” states Anne Whitake, president, North America Pharmaceuticals, Sanofi. “The availability of Auvi-Q represents an important step forward in our continued innovation to meet the needs of people at risk for anaphylaxis and their caregivers.”

Watch a video on Auvi-Q, or use the interactive model to see all the features at http://bit.ly/U2mNM4. www.sanofi.us

31mm Trunk-Ipsilateral Leg is 18Fr Compatible
W. L. Gore & Associates Inc. received CE Mark for the new lower profile 31mm diameter trunk-ipsilateral leg and 32mm aortic extender components of the GORE EXCLUDER AAA endoprosthesis for treatment of abdominal aortic aneurysms (AAAs). The reduced profile allows the trunk-ipsilateral leg component to be used with an 18Fr GORE DrySeal Sheath and allows the 32mm aortic extender component to be used with a 17Fr compatible sheath, making the GORE EXCLUDER device one of the lowest profiles for treating aortic necks with an inner diameter of 27mm to 29mm.

No changes have been made to the GORE EXCLUDER device, rather Gore has implemented a process using ePTFE materials to constrain the device onto the catheter.

See the GORE device in action at http://bit.ly/TfS3p5. www.goremedical.com